Savient Pharmaceuticals Inc.

Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results.(Financial report)
Biotech Week; 11/18/2009; 627 words; Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) reported financial...offering with our existing cash brings Savient to approximately $128.4 million in...Treatment, Savient Pharmaceuticals Inc. This article was prepared by Biotech...

Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results.
PR Newswire; 11/5/2009; 4481 words; ...PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. today reported financial results...with our existing cash brings Savient to approximately $128.4 million...Paul Hamelin, President of Savient. Operational Key Events...

Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 1226 words; ...counsel. Alnylam Pharmaceuticals Inc., of Cambridge...board. Panacea Pharmaceuticals Inc., of Gaithersburg...Pharmaceuticals Inc., of San Diego...Pharmaceuticals Inc., of Half Moon...discovery. Savient Pharmaceuticals Inc., of East Brunswick...

Other News To Note.
BIOWORLD Today; 11/3/2009; 1381 words; ...potential. o Callisto Pharmaceuticals Inc., of New York...of Akt. VioQuest Pharmaceuticals Inc., of Monmouth...quarter. o Peregrine Pharmaceuticals Inc., of Tustin...indications. o Savient Pharmaceuticals Inc., of East Brunswick...

Indevus Files For FDA Approval For Long-Acting Testosterone.
BIOWORLD Today; 11/3/2009; 1087 words; Staff Writer Indevus Pharmaceuticals Inc. filed with the FDA seeking...payment from Esprit Pharma Inc., its U.S. partner...Valera Pharmaceuticals Inc., of Cranbury, N...Delatestryl in January 2006 from Savient Pharmaceuticals Inc...